Indications and uses
For the relief of symptoms associated with seborrheic dermatitis, dandruff, and/or psoriasis, including: itching scaling flaking redness irritation of the skin. Helps prevent recurrence.
For the relief of symptoms associated with seborrheic dermatitis, dandruff, and/or psoriasis, including: itching scaling flaking redness irritation of the skin. Helps prevent recurrence.
Use only as directed. Apply to affected areas one to four times daily or as directed by a doctor. Massage well into affected areas. Optimally, this product should be applied to the scalp and left overnight.
Store at room temperature.
Drug Facts
Salicylic Acid 3%
For the relief of Seborrheic Dermatitis, Dandruff, and/or Psoriasis.
For the relief of symptoms associated with seborrheic dermatitis, dandruff, and/or psoriasis, including: itching
Helps prevent recurrence.
For external use only. Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Keep out of reach of children. If swallowed get medical help or call a poison control center immediately.
Use only as directed. Apply to affected areas one to four times daily or as directed by a doctor. Massage well into affected areas. Optimally, this product should be applied to the scalp and left overnight.
Acrylates/C10-30 Alkyl Acrylate Crosspolymer, BHT, C12-15 Alkyl Benzoate, Carbomer, Diazolidinyl Urea, Disodium EDTA, Glycerin, Methylparaben, Propylene Glycol, Propylparaben, Prunus Amigdalus Dulcis (Sweet Almond) Oil, Sesamum Indicum (Sesame) Seed Oil, Sodium Hydroxide, Sorbitan Oleate, Triethanolamine, Water.
call 1.800.635.0712 Monday through Friday 8:00 AM to 4:30 PM
Manufactured by: Pharmco Laboratories, Inc.
3520 South St. • Titusville, FL 32780
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58400-020 | 58400-020-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c928b708-4fc4-41e2-9653-a82a6834e526 | cbc12765-5fbd-4ac0-938e-0e90d1397a03 | 2024-12-23 | Warnings | c928b708-4fc4-41e2-9653-a82a6834e526 cbc12765-5fbd-4ac0-938e-0e90d1397a03 |
Adverse event summaries are temporarily unavailable. Other product information remains available.